Changes

Jump to navigation Jump to search
Line 48: Line 48:  
Laboratory tests are unlikely to show abnormalities until 36-72 hours after exposure, due to the delay in onset of haemorrhagic signs. Prothrombin time (PT) is a measure of functionality of the extrinsic (and common) pathway, and because factor VII has the shortest half life and thus becomes depleted most rapidly, this parameter is generally the first to become prolonged. Partial thromboplastin time (PTT) and activated clotting time (ACT) are related to the function of the intrinsic and common pathways, and usually become prolonged by 48-72 hours post-ingestion when levels of factor IX are reduced. Platelet count and buccal mucosal bleeding time assess platelet function, and since only secondary haemostasis is affected by vitamin K epoxide reductase antagonism, these measure are usually within normal limits.
 
Laboratory tests are unlikely to show abnormalities until 36-72 hours after exposure, due to the delay in onset of haemorrhagic signs. Prothrombin time (PT) is a measure of functionality of the extrinsic (and common) pathway, and because factor VII has the shortest half life and thus becomes depleted most rapidly, this parameter is generally the first to become prolonged. Partial thromboplastin time (PTT) and activated clotting time (ACT) are related to the function of the intrinsic and common pathways, and usually become prolonged by 48-72 hours post-ingestion when levels of factor IX are reduced. Platelet count and buccal mucosal bleeding time assess platelet function, and since only secondary haemostasis is affected by vitamin K epoxide reductase antagonism, these measure are usually within normal limits.
    +
The 'proteins induced by vitamin K antagonism'(PIVKA) are acarboxylated proteins that form as a result of anticoagulant rodenticide toxicity. PIVKAs are not normally detected in the circulation and are increased in the plasma of intoxicated animals. However, PIVKAs are rapidly cleared following adminstration of vitamin K, and so samples should be obtained before therapy is initiated.
   −
The so-called 'proteins induced by vitamin K antagonism'
+
It may also be possible to assay vitamin K epoxide and specific anticoagulant in the blood, but these tests are not normally necessary.
(PIVKA) are acarboxylated proteins formed as a
  −
result of anticoagulant rodenticide toxicity. While not
  −
normally detected in the circulation, these increase in the
  −
plasma of poisoned animals and can be detected using
  −
the PIVKA test which is available through some veterinary
  −
diagnostic laboratories. PIVKA are usually cleared
  −
within 12 hours of administration of vitamin K. Samples
  −
for coagulation testing should be collected before initiating
  −
vitamin K therapy.
  −
Other possible confirmatory tests include quantitation
  −
of vitamin K epoxide concentrations and determination
  −
of the specific anticoagulant in the blood, liver and/or
  −
stomach contents.
      
===Pathology===
 
===Pathology===
6,502

edits

Navigation menu